NCT00859261

Brief Summary

The study purpose is to help in the developement of 3 dimensional breast ultrasound imaging.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2009

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

March 9, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 11, 2009

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
Last Updated

May 5, 2016

Status Verified

May 1, 2016

Enrollment Period

5.9 years

First QC Date

March 9, 2009

Last Update Submit

May 3, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • To prove the significance/capability of 3D Ultrasound imaging in comparison to current mammographic imaging.

    Assess the quality of 3 D ultrasound in comparison to conventional mammography

    1 year

Study Arms (1)

Breast imaging using Ultrasound and Photoacoustic

EXPERIMENTAL

Evaluating 3D ultrasound for breast abnormalities/masses/cysts. This includes ultrasound imaging and possibly photoacoustic imaging.

Procedure: Experimental 3D Breast Ultrasound imagingProcedure: Experimental Photoacoustic Imaging

Interventions

Subjects will be seated and have the indicated breast positioned in the 3D breast ultrasound imaging device. An ultrasound gel will be applied to the breast by the technician. The breast will be gently compressed between the ultrasound plates to facilitate the 3D (dimensional)breast imaging. This imaging session will take approximately 30 minutes to complete.

Breast imaging using Ultrasound and Photoacoustic

Subjects will be placed in a seated position for the photoacoustic tomography(PAT) imaging. The subjects will be given a laser protective mask to wear. Each subject will be instructed how to wear this mask(goggles) to protect their eyes during the imaging session. Pulse monitor leads may be placed on their chest to allow the computer to record the images of blood flow in the breast. The breast will be placed on the laser device platform and positioned so that the laser beam is appropriately directed to the targeted area of the breast. During the imaging the temperature of the skin under laser light, will be checked often with a thermometer to make sure that the skin is not getting too hot. This laser based imaging scan will take approximately 10 minutes to complete.

Also known as: Photoacoustic Tomography (PAT)
Breast imaging using Ultrasound and Photoacoustic

Eligibility Criteria

Age30 Years - 80 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy women OR
  • Women with suspected benign masses who may/or may not be going to biopsy
  • Women with cysts where no biopsy is recommended

You may not qualify if:

  • Women who are pregnant
  • Women with breast implants
  • Prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Breast NeoplasmsBreast Cyst

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesCysts

Study Officials

  • Paul Carson, Ph.D.

    University of Michigan Basic Science Division

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator ( Ph.D )

Study Record Dates

First Submitted

March 9, 2009

First Posted

March 11, 2009

Study Start

March 1, 2009

Primary Completion

February 1, 2015

Study Completion

February 1, 2015

Last Updated

May 5, 2016

Record last verified: 2016-05

Data Sharing

IPD Sharing
Will not share

Locations